Acceleron Pharma Inc. Net Profit Margin 2013-2021 | XLRN
Acceleron Pharma Inc. net profit margin from 2013 to 2021. Net profit margin can be defined as net Income as a portion of total sales revenue.
Net Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Net Income |
Net Margin |
2021-09-30 |
$0.11B |
$-0.25B |
-224.78% |
2021-06-30 |
$0.10B |
$-0.22B |
-218.63% |
2021-03-31 |
$0.11B |
$-0.18B |
-155.26% |
2020-12-31 |
$0.09B |
$-0.17B |
-177.42% |
2020-09-30 |
$0.11B |
$-0.13B |
-124.53% |
2020-06-30 |
$0.09B |
$-0.14B |
-158.62% |
2020-03-31 |
$0.08B |
$-0.14B |
-184.00% |
2019-12-31 |
$0.07B |
$-0.13B |
-168.92% |
2019-09-30 |
$0.04B |
$-0.14B |
-348.72% |
2019-06-30 |
$0.04B |
$-0.12B |
-315.79% |
2019-03-31 |
$0.01B |
$-0.13B |
-935.71% |
2018-12-31 |
$0.01B |
$-0.12B |
-850.00% |
2018-09-30 |
$0.01B |
$-0.11B |
-800.00% |
2018-06-30 |
$0.01B |
$-0.11B |
-771.43% |
2018-03-31 |
$0.01B |
$-0.11B |
-838.46% |
2017-12-31 |
$0.01B |
$-0.11B |
-771.43% |
2017-09-30 |
$0.01B |
$-0.10B |
-761.54% |
2017-06-30 |
$0.01B |
$-0.10B |
-730.77% |
2017-03-31 |
$0.01B |
$-0.09B |
-669.23% |
2016-12-31 |
$0.03B |
$-0.06B |
-211.11% |
2016-09-30 |
$0.03B |
$-0.07B |
-232.14% |
2016-06-30 |
$0.03B |
$-0.06B |
-193.10% |
2016-03-31 |
$0.03B |
$-0.04B |
-137.50% |
2015-12-31 |
$0.02B |
$-0.06B |
-355.56% |
2015-09-30 |
$0.02B |
$-0.06B |
-305.56% |
2015-06-30 |
$0.02B |
$-0.05B |
-283.33% |
2015-03-31 |
$0.02B |
$-0.06B |
-362.50% |
2014-12-31 |
$0.02B |
$-0.05B |
-346.67% |
2014-09-30 |
$0.02B |
$-0.05B |
-204.35% |
2014-06-30 |
$0.02B |
$-0.06B |
-278.26% |
2014-03-31 |
$0.05B |
$-0.05B |
-102.22% |
2013-12-31 |
$0.06B |
$-0.04B |
-68.42% |
2013-09-30 |
$0.05B |
$-0.03B |
-67.35% |